Barclays’s Dynavax Technologies DVAX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-317,848
Closed -$4.89M 5143
2025
Q4
$4.89M Sell
317,848
-23,841
-7% -$263K ﹤0.01% 2237
2025
Q3
$3.39M Sell
341,689
-92,982
-21% -$968K ﹤0.01% 2485
2025
Q2
$4.31M Buy
434,671
+197,256
+83% +$2.08M ﹤0.01% 2254
2025
Q1
$3.08M Sell
237,415
-52,969
-18% -$701K ﹤0.01% 2300
2024
Q4
$3.71M Sell
290,384
-12,188
-4% -$147K ﹤0.01% 2418
2024
Q3
$3.37M Buy
302,572
+175,118
+137% +$1.93M ﹤0.01% 2421
2024
Q2
$1.43M Sell
127,454
-24,668
-16% -$287K ﹤0.01% 2368
2024
Q1
$1.89M Sell
152,122
-250,312
-62% -$3.26M ﹤0.01% 2617
2023
Q4
$5.63M Buy
402,434
+124,268
+45% +$1.73M ﹤0.01% 1990
2023
Q3
$4.11M Buy
278,166
+24,156
+10% +$340K ﹤0.01% 1444
2023
Q2
$3.28M Buy
254,010
+25,192
+11% +$287K ﹤0.01% 1595
2023
Q1
$2.24M Sell
228,818
-150,343
-40% -$1.6M ﹤0.01% 2107
2022
Q4
$4.03M Sell
379,161
-18,340
-5% -$213K ﹤0.01% 1772
2022
Q3
$4.15M Buy
397,501
+359,235
+939% +$4.68M ﹤0.01% 1279
2022
Q2
$482K Sell
38,266
-79,287
-67% -$842K ﹤0.01% 2890
2022
Q1
$1.27M Sell
117,553
-18,841
-14% -$229K ﹤0.01% 2209
2021
Q4
$1.92M Buy
136,394
+91,832
+206% +$1.51M ﹤0.01% 2410
2021
Q3
$856K Sell
44,562
-113,550
-72% -$1.51M ﹤0.01% 2872
2021
Q2
$1.56M Sell
158,112
-231,354
-59% -$2.1M ﹤0.01% 2364
2021
Q1
$3.83M Buy
389,466
+334,454
+608% +$2.76M ﹤0.01% 1747
2020
Q4
$243K Sell
55,012
-952
-2% -$4.31K ﹤0.01% 3654
2020
Q3
$242K Sell
55,964
-8,107
-13% -$57.8K ﹤0.01% 3726
2020
Q2
$568K Buy
64,071
+1,853
+3% +$9.37K ﹤0.01% 3240
2020
Q1
$220K Sell
62,218
-50,224
-45% -$233K ﹤0.01% 4228
2019
Q4
$644K Buy
112,442
+44,102
+65% +$236K ﹤0.01% 4073
2019
Q3
$244K Buy
68,340
+19,205
+39% +$74.5K ﹤0.01% 4823
2019
Q2
$196K Buy
49,135
+19,155
+64% +$111K ﹤0.01% 5128
2019
Q1
$220K Buy
+29,980
New +$293K ﹤0.01% 4749
2018
Q4
Sell
-24,737
Closed -$307K 7021
2018
Q3
$307K Sell
24,737
-11,984
-33% -$162K ﹤0.01% 4669
2018
Q2
$559K Sell
36,721
-6,862
-16% -$119K ﹤0.01% 3837
2018
Q1
$865K Sell
43,583
-41,973
-49% -$725K ﹤0.01% 3383
2017
Q4
$1.6M Sell
85,556
-14,629
-15% -$294K ﹤0.01% 2653
2017
Q3
$2.15M Buy
100,185
+78,307
+358% +$1.24M ﹤0.01% 2267
2017
Q2
$211K Buy
21,878
+21,005
+2,406% +$136K ﹤0.01% 4311
2017
Q1
$4K Buy
873
+212
+32% +$1.02K ﹤0.01% 6320
2016
Q4
$2K Sell
661
-56,665
-99% -$415K ﹤0.01% 6340
2016
Q3
$601K Buy
+57,326
New +$824K ﹤0.01% 3069
2016
Q1
Sell
-27,900
Closed -$670K 6200
2015
Q4
$670K Buy
27,900
+27,432
+5,862% +$687K ﹤0.01% 2956
2015
Q3
$11K Sell
468
-129,431
-100% -$3.67M ﹤0.01% 5733
2015
Q2
$2.99M Buy
129,899
+25,977
+25% +$566K ﹤0.01% 1891
2015
Q1
$2.29M Buy
103,922
+102,215
+5,988% +$1.96M ﹤0.01% 2186
2014
Q4
$27K Buy
1,707
+784
+85% +$11.9K ﹤0.01% 6134
2014
Q3
$9K Buy
923
+459
+99% +$6.62K ﹤0.01% 6936
2014
Q2
$4K Sell
464
-1,494
-76% -$22.5K ﹤0.01% 7184
2014
Q1
$19K Sell
1,958
-771
-28% -$14.3K ﹤0.01% 6630
2013
Q4
$27K Buy
2,729
+2,054
+304% +$30.1K ﹤0.01% 6547
2013
Q3
$7K Sell
675
-11,680
-95% -$147K ﹤0.01% 6890
2013
Q2
$136K Buy
+12,355
New +$260K ﹤0.01% 5531

Other funds holding DVAX

Barclays's DVAX Position: Q1 2026 in Review

Barclays sold out of Dynavax Technologies (DVAX) in Q1 2026, closing a stake of 317,848 shares — an estimated $4.89M sold.

Barclays first reported a position in DVAX in Q2 2013 and held it in 48 quarters. The position peaked at $5.63M in Q4 2023. 1 fund tracked by Wall St. Rank holds DVAX as of Q1 2026.

  • Barclays reported no remaining Dynavax Technologies position as of Q1 2026 after selling out during the quarter.
  • Barclays sold 317,848 Dynavax Technologies shares in Q1 2026, an estimated $4.89M.
  • Barclays first reported a position in Dynavax Technologies in Q2 2013 and held it in 48 quarters.
  • Barclays's Dynavax Technologies position peaked at $5.63M in Q4 2023.
  • 1 fund tracked by Wall St. Rank held Dynavax Technologies as of Q1 2026.

Based on Barclays's 13F filing for Q1 2026, filed 15 May 2026.